Why lithium should be used in patients with bipolar disorder? A scoping review and an expert opinion paper

References

• Fava GA, Guidi J. The pursuit of euthymia. World Psychiatry. 2020 Feb;19(1):40–50. PMID: 31922678; PMCID: PMC7254162.
   PubMed Web of Science ®Google Scholar
• Fountoulakis KN, Tohen M, Zarate CA, et al. Lithium treatment of Bipolar disorder in adults: a systematic review of randomized trials and meta-analyses. Eur Neuropsychopharmacol. 2022;54:100–115.
   PubMed Web of Science ®Google Scholar
• Tondo L, Vázquez GH, Baldessarini RJ, et al. Prevention of suicidal behavior in bipolar disorder. Bipolar Disord. 2021;23(1):14–23.
   PubMed Web of Science ®Google Scholar
• Hayes SC. SC . Constructing a liberated and modern mind: six pathways from pathology to euthymia. World Psychiatry. 2020;19(1):51–52.
   PubMed Web of Science ®Google Scholar
• MacLeod A. Euthymia: why it really does matter. World Psychiatry. 2020 Feb;19(1):1–2.
   PubMed Web of Science ®Google Scholar
• Ochoa ELM. Lithium as a neuroprotective agent for bipolar disorder: an overview. Cell Mol Neurobiol. 2022 Jan;42(1):85–97. PMID: 34357564.
   PubMed Web of Science ®Google Scholar
• Puglisi-Allegra S, Ruggieri S, Fornai F. Translational evidence for lithium-induced brain plasticity and neuroprotection in the treatment of neuropsychiatric disorders. Transl Psychiatry. 2021;11(1):366. PMID: 34226487.
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Alda M, Baldessarini RJ, et al. The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management. World Psychiatry. 2022 Oct;21(3):364–387.
   PubMed Web of Science ®Google Scholar
• Cade JF. Lithium salts in the treatment of psychotic excitement. Med J Aust. 1949 Sep 3;2(10):349–352.
   PubMed Web of Science ®Google Scholar
• DeFeudis FV, Delgado JM. Effects of lithium on amino-acids in mouse brain in vivo. Nature. 1970;225(5234):749–750.
   PubMed Web of Science ®Google Scholar
• Amdisen A. Serum level monitoring and clinical pharmacokinetics of lithium. Clin Pharmacokinet. 1977 Mar-Apr;2(2):73–92. PMID: 324690.
   PubMed Web of Science ®Google Scholar
• Tondo L, Alda M, Bauer M, et al.; International Group for Studies of Lithium (IGSLi). Clinical use of lithium salts: guide for users and prescribers. Int J Bipolar Disord. 2019 Jul 22;7(1):16. PMID: 31328245; PMCID: PMC6643006.
   PubMedGoogle Scholar
• Baldessarini RJ, Tondo L, Viguera AC. Discontinuing lithium maintenance treatment in bipolar disorders: risks and implications. Bipolar Disord. 1999;1(1):17–24.
   PubMedGoogle Scholar
• Severus E, Taylor MJ, Sauer C, et al. Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis. Int J Bipolar Disord. 2014;2(1):15.
   PubMedGoogle Scholar
• Grillault Laroche D, Etain B, Severus E, et al. ISBD-IGSLI joint task force on lithium treatment. Socio-demographic and clinical predictors of outcome to long-term treatment with lithium in bipolar disorders: a systematic review of the contemporary literature and recommendations from the ISBD/IGSLI task force on treatment with lithium. Int J Bipolar Disord. 2020;8(1):40.
   PubMed Web of Science ®Google Scholar
• Grillault Laroche D, Godin O, Dansou Y, et al. Influence of childhood maltreatment on prevalence, onset, and persistence of psychiatric comorbidities and suicide attempts in bipolar disorders. Eur Psychiatry. 2022 Jan 21;65(1):e15. PMID: 35060460; PMCID: PMC8853858.
   PubMed Web of Science ®Google Scholar
• Rybakowski J. Lithium treatment - the state of the art for 2020. Psychiatr Pol. 2020;54(6):1047–1066.
   PubMed Web of Science ®Google Scholar
• Correll CU, Cortese S, Croatto G, et al. Efficacy and acceptability of pharmacological, psychosocial, and brain stimulation interventions in children and adolescents with mental disorders: an umbrella review. World Psychiatry. 2021 Jun;20(2):244–275.
   PubMed Web of Science ®Google Scholar
• Taipale H, Tanskanen A, Mehtälä J, et al. 20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20). World Psychiatry. 2020 Feb;19(1):61–68.
   PubMed Web of Science ®Google Scholar
• Solmi M, Fornaro M, Ostinelli EG, et al. Safety of 80 antidepressants, antipsychotics, anti-attention-deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects. World Psychiatry. 2020 Jun;19(2):214–232.
   PubMed Web of Science ®Google Scholar
• Naguy A, Alamiri B. Lithium beyond bipolar mood disorders: a hope or hype? Prim Care Companion CNS Disord. 2022;24(5):21br03109.
   PubMedGoogle Scholar
• Sepede G, Lorusso M, Spano MC, et al. Efficacy and Safety of Atypical Antipsychotics in Bipolar Disorder with Comorbid Substance Dependence: A Systematic Review. Clin Neuropharmacol. 2018 Sep/Oct;41(5):181–191. doi: 10.1097/WNF.0000000000000297. PMID: 30036197
   PubMed Web of Science ®Google Scholar
• DelBello MP, Kadakia A, Heller V, et al. Systematic review and network meta-analysis: efficacy and safety of second-generation antipsychotics in youths with bipolar depression. J Am Acad Child Adolesc Psychiatry. 2022 Feb;61(2):243–254. Epub 2021 May 4. PMID: 34420839.
   PubMed Web of Science ®Google Scholar
• Kadakia A, Dembek C, Heller V, et al. Efficacy and tolerability of atypical antipsychotics for acute bipolar depression: a network meta-analysis. BMC Psychiatry. 2021 May 11;21(1):249. PMID: 33975574; PMCID: PMC8112003.
   PubMed Web of Science ®Google Scholar
• Ogasawara M, Takeshima M, Esaki Y, et al. Comparison of the efficacy and safety of quetiapine and lithium for bipolar depression: a systematic review and meta-analysis of randomized controlled trials. Neuropsychopharmacol Rep. 2022 Jul 20;42(4):410–420. Epub ahead of print. PMID: 35858678.
   PubMed Web of Science ®Google Scholar
• Hayes JF, Marston L, Walters K, et al. Adverse renal, endocrine, hepatic, and metabolic events during maintenance mood stabilizer treatment for bipolar disorder: a population-based cohort study. PLoS Med. 2016 Aug 2;13(8):e1002058. PMID: 27483368; PMCID: PMC4970809.
   PubMed Web of Science ®Google Scholar
• Kishi T, Ikuta T, Matsuda Y, et al. Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials. Mol Psychiatry. 2021 Aug;26(8):4146–4157. Epub 2020 Nov 11. PMID: 33177610; PMCID: PMC8550938.
   PubMed Web of Science ®Google Scholar
• Appelbaum PS Malpractice claims in psychiatry: approaches to reducing risk . World Psychiatry. : ; 2021 20 3 . p. 438–439.
   PubMed Web of Science ®Google Scholar
• Shorter E. The history of lithium therapy. Bipolar Disord. 2009 Jun ;11;2(2):4–9.
   Google Scholar
• Martinotti G, Pettorruso M, De Berardis D, et al. Utilizzo clinico del litio e nuova formulazione a rilascio prolungato: risultati di una survey su psichiatri italiani [Clinical use of lithium and new retard formulation: results of a survey on italian psychiatrists]. Riv Psichiatr. 2020 Sep-Oct;55(5):269–280.
   PubMedGoogle Scholar
• Hasler G. Understanding mood in mental disorders. World Psychiatry. 2020 Feb;19(1):56–57. PMID: 31922695; PMCID: PMC6953576.
   PubMed Web of Science ®Google Scholar
• Chaturvedi SK, Parameshwaran S. The pursuit of euthymia: are cultural factors relevant? World Psychiatry. 2020 Feb;19(1):59–60.
   PubMed Web of Science ®Google Scholar
• Slade M, Sweeney A. Rethinking the concept of insight. World Psychiatry. 2020 Oct;19(3):389–390.
   PubMed Web of Science ®Google Scholar
• Luo H, Chevillard L, Bellivier F, et al. The role of brain barriers in the neurokinetics and pharmacodynamics of lithium. Pharmacol Res. 2021;166:105480.
   PubMed Web of Science ®Google Scholar
• Wen J, Sawmiller D, Wheeldon B, et al. A review for lithium: pharmacokinetics, drug design, and toxicity. CNS Neurol Disord Drug Targets. 2019;18(10):769–778.
   PubMed Web of Science ®Google Scholar
• McKnight RF, Adida M, Budge K, et al. Lithium toxicity profile: a systematic review and meta-analysis. Lancet. 2012 Feb 25;379(9817):721–728.
   PubMed Web of Science ®Google Scholar
• Albert U, De Cori D, Aguglia A, et al. Effects of maintenance lithium treatment on serum parathyroid hormone and calcium levels: a retrospective longitudinal naturalistic study. Neuropsychiatr Dis Treat. 2015 Jul 20;11:1785–1791.
   PubMed Web of Science ®Google Scholar
• Albert U, De Cori D, Aguglia A, et al. Lithium-associated hyperparathyroidism and hypercalcaemia: a case-control cross-sectional study. J Affect Disord. 2013 Nov;151(2):786–790.
   PubMed Web of Science ®Google Scholar
• Albert U, De Cori D, Blengino G, et al. Trattamento con litio e potenziali effetti collaterali a lungo termine: una revisione sistematica della letteratura [Lithium treatment and potential long-term side effects: a systematic review of the literature]. Riv Psichiatr. 2014 Jan-Feb;49(1):12–21.
   PubMedGoogle Scholar
• Barbuti M, Colombini P, Ricciardulli S, et al. Treatment adherence and tolerability of immediate- and prolonged-release lithium formulations in a sample of bipolar patients: a prospective naturalistic study. Int Clin Psychopharmacol. 2021;36(5):230–237.
   PubMed Web of Science ®Google Scholar
• Grandjean EM, Aubry JM. Lithium: updated human knowledge using an evidence-based approach. Part II: clinical pharmacology and therapeutic monitoring. CNS Drugs. 2009;23(4):331–349.
   PubMed Web of Science ®Google Scholar
• Pelacchi F, Dell’Osso L, Bondi E, et al., SALT Study Group. Clinical evaluation of switching from immediate-release to prolonged-release lithium in bipolar patients, poorly tolerant to lithium immediate-release treatment: a randomized clinical trial. Brain Behav. 2022;12(3):e2485.
   PubMed Web of Science ®Google Scholar
• Finley PR. Drug Interactions with Lithium: an update. Clin Pharmacokinet. 2016 Aug;55(8):925–941.
   PubMed Web of Science ®Google Scholar
• Girardi P, Brugnoli R, Manfredi G, et al. Lithium in bipolar disorder: optimizing therapy using prolonged-release formulations. Drugs R D. 2016 Dec;16(4):293–302.
   PubMedGoogle Scholar
• Pacchiarotti I, Anmella G, Colomer L, et al. How to treat mania. Acta Psychiatr Scand. 2020;142(3):173–192.
   PubMed Web of Science ®Google Scholar
• Malhi GS, Bell E, Boyce P, et al. The 2020 Royal Australian and New Zealand college of psychiatrists clinical practice guidelines for mood disorders: bipolar disorder summary. Bipolar Disord. 2020;22(8):805–821.
   PubMed Web of Science ®Google Scholar
• Nolen WA, Licht RW, Young AH, et al. ISBD/IGSLI task force on the treatment with lithium. What is the optimal serum level for lithium in the maintenance treatment of bipolar disorder? A systematic review and recommendations from the ISBD/IGSLI task force on treatment with lithium. Bipolar Disord. 2019 Aug;21(5):394–409.
   PubMed Web of Science ®Google Scholar
• Waring WS. Management of lithium toxicity. Toxicol Rev. 2006;25(4):221–230.
   PubMedGoogle Scholar
• Malhi GS, Gershon S, Outhred T. Lithiumeter: version 2.0. Bipolar Disord. 2016;18(8):631–641.
   PubMed Web of Science ®Google Scholar
• Bellivier F, Marie-Claire C. Molecular signatures of lithium treatment: current knowledge. Pharmacopsychiatry. 2018;51(5):212–219.
   PubMed Web of Science ®Google Scholar
• Forlenza OV, De-Paula VJ, Diniz BS. Neuroprotective effects of lithium: implications for the treatment of Alzheimer’s disease and related neurodegenerative disorders. ACS Chem Neurosci. 2014;5(6):443–450.
   PubMed Web of Science ®Google Scholar
• Miller AH , et al. Beyond depression: the expanding role of inflammation in psychiatric disorders. World Psychiatry. 2020;19(1):108–109.
   PubMed Web of Science ®Google Scholar
• Caraci F, Gulisano W, Guida CA, et al. A key role for TGF-β1 in hippocampal synaptic plasticity and memory. Sci Rep. 2015;5(1):11252.
   PubMedGoogle Scholar
• Caraci F, Battaglia G, Bruno V, et al. TGF-β1 pathway as a new target for neuroprotection in Alzheimer’s disease. CNS Neurosci Ther. 2011;17(4):237–249.
   PubMed Web of Science ®Google Scholar
• Li H, Hong W, Zhang C, et al. IL-23 and TGF-β1 levels as potential predictive biomarkers in treatment of bipolar I disorder with acute manic episode. J Affect Disord. 2015;174:361–366.
   PubMed Web of Science ®Google Scholar
• Machado-Vieira R, Yuan P, Brutsche N, et al. Brain-derived neurotrophic factor and initial antidepressant response to an N-methyl-D-aspartate antagonist. J Clin Psychiatry. 2009;70(12):1662–1666.
   PubMed Web of Science ®Google Scholar
• Lyoo IK, Dager SR, Kim JE, et al. Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: a longitudinal brain imaging study. Neuropsychopharmacology. 2010;35(8):1743–1750.
   PubMed Web of Science ®Google Scholar
• Moore GJ, Cortese BM, Glitz DA, et al. A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients. J Clin Psychiatry. 2009;70(5):699–705.
   PubMed Web of Science ®Google Scholar
• Selek S, Nicoletti M, Zunta-Soares GB, et al. A longitudinal study of fronto-limbic brain structures in patients with bipolar I disorder during lithium treatment. J Affect Disord. 2013 Sep 5;150(2):629–633.
   PubMed Web of Science ®Google Scholar
• Yucel K, Taylor VH, McKinnon MC, et al. Bilateral hippocampal volume increase in patients with bipolar disorder and short-term lithium treatment. Neuropsychopharmacology. 2008 Jan;33(2):361–367.
   PubMed Web of Science ®Google Scholar
• Eker C, Simsek F, Yılmazer EE, et al. Brain regions associated with risk and resistance for bipolar I disorder: a voxel-based MRI study of patients with bipolar disorder and their healthy siblings. Bipolar Disord. 2014 May;16(3):249–261. Epub 2014 Mar 4. PMID: 24589068.
   PubMed Web of Science ®Google Scholar
• Wijeratne C, Sachdev S, Wen W, et al. Hippocampal and amygdala volumes in an older bipolar disorder sample. Int Psychogeriatr. 2013;25(1):54–60.
   PubMed Web of Science ®Google Scholar
• Selvaraj S, Arnone D, Job D, et al. Grey matter differences in bipolar disorder: a meta-analysis of voxel-based morphometry studies. Bipolar Disord. 2012;14(2):135–145.
   PubMed Web of Science ®Google Scholar
• Kempton MJ, Geddes JR, Ettinger U, et al. Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder. Arch Gen Psychiatry. 2008;65(9):1017–1032.
   PubMed Web of Science ®Google Scholar
• Sun YR, Herrmann N, Scott CJM, et al. Global grey matter volume in adult bipolar patients with and without lithium treatment: a meta-analysis. J Affect Disord. 2018;225:599–606.
   PubMed Web of Science ®Google Scholar
• Kessing LV, Andersen PK. Does the risk of developing dementia increase with the number of episodes in patients with depressive disorder and in patients with bipolar disorder? J Neurol Neurosurg Psychiatry. 2004;75(12):1662–1666.
   PubMed Web of Science ®Google Scholar
• Nunes PV, Forlenza OV, Gattaz WF. Lithium and risk for Alzheimer’s disease in elderly patients with bipolar disorder. Br J Psychiatry. 2007;190(4):359–360.
   PubMed Web of Science ®Google Scholar
• Baldessarini RJ, Tondo L, Vázquez GH. Pharmacological treatment of adult bipolar disorder. Mol Psychiatry. 2019;24(2):198–217.
   PubMed Web of Science ®Google Scholar
• Bauer R, Glenn T, Strejilevich S, et al. Internet use by older adults with bipolar disorder: international survey results. Int J Bipolar Disord. 2018;6(1):20.
   PubMedGoogle Scholar
• Malhi GS, Gessler D, Outhred T. The use of lithium for the treatment of bipolar disorder: recommendations from clinical practice guidelines. J Affect Disord. 2017;217:266–280.
   PubMed Web of Science ®Google Scholar
• Yatham LN, Kennedy SH, Parikh SV, et al. Canadian network for mood and anxiety treatments (CANMAT) and international society for bipolar disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018;20(2):97–170.
   PubMed Web of Science ®Google Scholar
• Rybakowski JK, Chlopocka-Wozniak M, Suwalska A. The prophylactic effect of long-term lithium administration in bipolar patients entering treatment in the 1970s and 1980s. Bipolar Disord. 2001;3(2):63–67.
   PubMed Web of Science ®Google Scholar
• Popovic D, Reinares M, Goikolea JM, et al. Polarity index of pharmacological agents used for maintenance treatment of bipolar disorder. Eur Neuropsychopharmacol. 2012 May;22(5):339–346.
   PubMed Web of Science ®Google Scholar
• Miura T, Noma H, Furukawa TA, et al. Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis. Lancet Psychiatry. 2014;1(5):351–359.
   PubMed Web of Science ®Google Scholar
• Rakofsky JJ, Lucido MJ, Dunlop BW. Lithium in the treatment of acute bipolar depression: a systematic review and meta-analysis. J Affect Disord. 2022 Jul 1;308:268–280.
   PubMed Web of Science ®Google Scholar
• Malhi GS, Bell E, Hamilton A, et al. Lithium mythology. Bipolar Disord. 2021;23(1):7–10.
   PubMed Web of Science ®Google Scholar
• Jones G, Rong C, Vecera CM, et al. The role of lithium treatment on comorbid anxiety symptoms in patients with bipolar depression. J Affect Disord. 2022;308:71–75.
   PubMed Web of Science ®Google Scholar
• Goodwin FK, Whitham EA, Ghaemi SN. Maintenance treatment study designs in bipolar disorder: do they demonstrate that atypical neuroleptics (antipsychotics) are mood stabilizers? CNS Drugs. 2011;25(10):819–827.
   PubMed Web of Science ®Google Scholar
• Cipriani A, Barbui C, Rendell J, et al. Clinical and regulatory implications of active run-in phases in long-term studies for bipolar disorder. Acta Psychiatr Scand. 2014;129(5):328–342.
   PubMed Web of Science ®Google Scholar
• Hsu CW, Carvalho AF, Tsai SY, et al. Lithium concentration and recurrence risk during maintenance treatment of bipolar disorder: multicenter cohort and meta-analysis. Acta Psychiatr Scand. 2021;144(4):368–378.
   PubMed Web of Science ®Google Scholar
• Smith KA, Cipriani A. Lithium and suicide in mood disorders: updated meta-review of the scientific literature. Bipolar Disord. 2017;19(7):575–586.
   PubMed Web of Science ®Google Scholar
• Hayes JF, Pitman A, Marston L, et al. Self-harm, unintentional injury, and suicide in bipolar disorder during maintenance mood stabilizer treatment: a UK population-based electronic health records study. JAMA Psychiatry. 2016;73(6):630–637.
   PubMed Web of Science ®Google Scholar
• Hayes SC. Constructing a liberated and modern mind: six pathways from pathology to euthymia. World Psychiatry. 2020;19(1):51–52.
   PubMed Web of Science ®Google Scholar
• Song J, Sjölander A, Joas E, et al. Suicidal behavior during lithium and valproate treatment: a within-individual 8-year prospective study of 50,000 patients with bipolar disorder. Am J Psychiatry. 2017;174(8):795–802.
   PubMed Web of Science ®Google Scholar
• Antolín-Concha D, Lähteenvuo M, Vattulainen P, et al. Suicide mortality and use of psychotropic drugs in patients hospitalized due to bipolar disorder: a finnish nationwide cohort study. J Affect Disord. 2020;277:885–892.
   PubMed Web of Science ®Google Scholar
• Memon A, Rogers I, Smdd F, et al. Association between naturally occurring lithium in drinking water and suicide rates: systematic review and meta-analysis of ecological studies. Br J Psychiatry. 2020 Dec;217(6):667–678. PMID: 32716281.
   PubMed Web of Science ®Google Scholar
• Investigators BALANCE, Collaborators GJR, Goodwin GM, et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet. 2010;375(9712):385–395.
   PubMed Web of Science ®Google Scholar
• Lin Y, Maihofer AX, Stapp E, et al. Clinical predictors of non-response to lithium treatment in the pharmacogenomics of bipolar disorder (PGBD) study. Bipolar Disord. 2021 Dec;23(8):821–831.
   PubMed Web of Science ®Google Scholar
• Burdick KE, Millett CE, Russo M, et al. The association between lithium use and neurocognitive performance in patients with bipolar disorder. Neuropsychopharmacology. 2020 Sep;45(10):1743–1749.
   PubMed Web of Science ®Google Scholar
• Nierenberg AA, McElroy SL, Friedman ES, et al. Bipolar CHOICE (clinical health outcomes initiative in comparative effectiveness): a pragmatic 6-month trial of lithium versus quetiapine for bipolar disorder. J Clin Psychiatry. 2016 Jan;77(1):90–99.
   PubMed Web of Science ®Google Scholar
• Nierenberg AA, Friedman ES, Bowden CL, et al. Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium. Am J Psychiatry. 2013 Jan;170(1):102–110. PMID: 23288387.
   PubMed Web of Science ®Google Scholar
• Gao K, Arnold JG, Prihoda TJ, et al. Sequential multiple assignment randomized treatment (SMART) for bipolar disorder at any phase of illness and at least mild symptom severity. Psychopharmacol Bull. 2020 May 19;50(2):8–25. PMID: 32508363; PMCID: PMC7255841.
   Google Scholar
• Gao K, Goto T, Yuan C, et al. A pilot study of the effectiveness of lithium versus quetiapine immediate release monotherapy in patients with bipolar spectrum disorders. J Clin Psychopharmacol. 2018;38(5):422–434.
   PubMed Web of Science ®Google Scholar
• Bowden CL A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Arch Gen Psychiatry. 2000;57(5):481–489. DOI:10.1001/archpsyc.57.5.481
   PubMed Web of Science ®Google Scholar
• Calabrese JR, Rapport DJ, Youngstrom EA, et al. New data on the use of lithium, divalproate, and lamotrigine in rapid cycling bipolar disorder. Eur Psychiatry. 2005;20(2):92–95.
   PubMed Web of Science ®Google Scholar
• Carroll B, Thalassinos A, Fawver J. Loading Strategies in Acute Mania. CNS Spectr. 2001;6(11):919–922, 930.
   PubMedGoogle Scholar
• Baldessarini RJ, Tondo L, Davis P, et al. Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disord. 2006;8(5 Pt 2):625–639.
   PubMed Web of Science ®Google Scholar
• Tondo L, Baldessarini RJ, Hennen J, et al. Lithium treatment and risk of suicidal behavior in bipolar disorder patients. J Clin Psychiatry. 1998;59(8):405–414. doi:10.4088/JCP.v59n0802PubMedGoogle ScholarCrossref.
   PubMed Web of Science ®Google Scholar
• Köhler-Forsberg O, Sylvia LG, Thase M, et al. Lithium plus antipsychotics or anticonvulsants for bipolar disorder: comparing clinical response and metabolic changes. Aust N Z J Psychiatry. 2022 Feb;15:48674221077619.
   Google Scholar
• Inoue T, Sano H, Kojima Y, et al. Real-world treatment patterns and adherence to oral medication among patients with bipolar disorders: a retrospective, observational study using a healthcare claims database. Neuropsychiatr Dis Treat. 2021;17:821–833.
   PubMed Web of Science ®Google Scholar
• Lähteenvuo M, Tanskanen A, Taipale H, et al. Real-world effectiveness of pharmacologic treatments for the prevention of rehospitalization in a finnish nationwide cohort of patients with bipolar disorder. JAMA Psychiatry. 2018 Apr 1;75(4):347–355. Erratum in: JAMA Psychiatry. 2022 May 1;79(5):516. PMID: 29490359; PMCID: PMC5875349
   PubMed Web of Science ®Google Scholar
• Kowatch RA, Suppes T, Carmody TJ, et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2000;39(6):713–720.
   PubMed Web of Science ®Google Scholar
• Geller B, Luby JL, Joshi P, et al. A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents. Arch Gen Psychiatry. 2012;69(5):515–528.
   PubMed Web of Science ®Google Scholar
• Masi G, Milone A, Scrinzi G, et al. Lithium treatment in bipolar adolescents: a follow-up naturalistic study. Neuropsychiatr Dis Treat. 2018;14:2749–2753.
   PubMed Web of Science ®Google Scholar
• Findling RL, Kafantaris V, Pavuluri M, et al. Dosing strategies for lithium monotherapy in children and adolescents with bipolar I disorder. J Child Adolesc Psychopharmacol. 2011;21(3):195–205.
   PubMed Web of Science ®Google Scholar
• Squeglia LM. Alcohol and the developing adolescent brain. World Psychiatry. 2020;19(3):393–394.
   PubMed Web of Science ®Google Scholar
• Patino LR, Klein CC, Strawn JR, et al. A randomized, double-blind, controlled trial of lithium versus quetiapine for the treatment of acute mania in youth with early course bipolar disorder. J Child Adolesc Psychopharmacol. 2021;31(7):485–493.
   PubMed Web of Science ®Google Scholar
• Washburn JJ, West AE, Heil JA. Treatment of pediatric bipolar disorder: a Review. Minerva Psichiatr. 2011;52(1):21–35.
   PubMedGoogle Scholar
• Rosen MS, Lijffijt M. Lithium in child and adolescent bipolar disorder. Am J Psychiatry. 2017;1:3–5. DOI:10.1176/appi.ajp.2016.16101154
   PubMedGoogle Scholar
• Arnold I, Dehning J, Grunze A, et al. Old age bipolar disorder-epidemiology, aetiology and treatment. Medicina (Kaunas). 2021 Jun 8;57(6):587. PMID: 34201098; PMCID: PMC8226928.
   PubMed Web of Science ®Google Scholar
• Young RC, Mulsant BH, Sajatovic M, et al. GERI-BD study group. GERI-BD: a randomized double-blind controlled trial of lithium and divalproex in the treatment of mania in older patients with bipolar disorder. Am J Psychiatry. 2017;174(11):1086–1093.
   PubMed Web of Science ®Google Scholar
• Dols A, Kessing LV, Strejilevich SA, et al. International society for bipolar disorders task force for older adults with bipolar disorder. Do current national and international guidelines have specific recommendations for older adults with bipolar disorder? A brief report. Int J Geriatr Psychiatry. 2016;31(12):1295–1300.
   PubMed Web of Science ®Google Scholar
• Ishii N, Terao T, Hirakawa H. The present state of lithium for the prevention of dementia related to alzheimer’s dementia in clinical and epidemiological studies: a critical review. Int J Environ Res Public Health. 2021 Jul 22;18(15):7756.
   PubMed Web of Science ®Google Scholar
• Almeida OP, Singulani MP, Ford AH, et al. Lithium and stroke recovery: a systematic review and meta-analysis of stroke models in rodents and human data. Stroke. 2022;53(9):2935–2944.
   PubMed Web of Science ®Google Scholar
• Lassas A, Norrback KF, Adolfsson R, et al. Bipolar disorder and bone mineral density Z-scores in relation to clinical characteristics and lithium medication. J Clin Med. 2022 Dec 1;11(23):7158. PMID: 36498732; PMCID: PMC9739939.
   PubMed Web of Science ®Google Scholar
• Köhler-Forsberg O, Rohde C, Nierenberg AA, et al. Association of lithium treatment with the risk of osteoporosis in patients with bipolar disorder. JAMA Psychiatry. 2022 May 1;79(5):454–463. PMID: 35353126; PMCID: PMC8968656.
   PubMed Web of Science ®Google Scholar
• Burton C, Mathys M, Gutierrez E. Comparison of lithium to second generation antipsychotics for the treatment of bipolar disorder in older veterans. Psychiatry Res. 2021 Sep;303:114063.
   PubMed Web of Science ®Google Scholar
• Volkmann C, Bschor T, Köhler S. Lithium treatment over the lifespan in bipolar disorders. Front Psychiatry. 2020;11:377.
   PubMed Web of Science ®Google Scholar
• Janiri D, Nicola M, Martinotti G, et al. Who’s the leader, mania or depression? Predominant polarity and alcohol/polysubstance use in bipolar disorders. Curr Neuropharmacol. 2017;15(3):409–416.
   PubMed Web of Science ®Google Scholar
• Grant BF, Stinson FS, Hasin DS, et al. Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry. 2005;66(10):1205–1215.
   PubMed Web of Science ®Google Scholar
• Geller B, Cooper T, Sun K, et al. Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. J Am Acad Child Adolesc Psychiatry. 1998;37(2):171–178.
   PubMed Web of Science ®Google Scholar
• Alda M, Manchia M. Personalized management of bipolar disorder. Neurosci Lett. 2018 Mar 16;669:3–9.
   PubMed Web of Science ®Google Scholar
• Gadh S. Low-dose lithium impact in an addiction treatment setting. Personalized Medicine in Psychiatry. 2020;21(22).
   Google Scholar
• Wesseloo R, Wierdsma AI, van Kamp Il, et al. Lithium dosing strategies during pregnancy and the postpartum period. Br J Psychiatry. 2017 Jul;211(1):31–36.
   PubMed Web of Science ®Google Scholar
• Wieck A. Prevention of bipolar episodes with lithium in the perinatal period. Br J Psychiatry. 2017 Jul;211(1):3–4. PMID: 28673942.
   PubMed Web of Science ®Google Scholar
• Molenaar NM, Poels EMP, Robakis T, et al. Management of lithium dosing around delivery: an observational study. Bipolar Disord. 2021 Feb;23(1):49–54.
   PubMed Web of Science ®Google Scholar
• Poels EMP, Bijma HH, Galbally M, et al. Lithium during pregnancy and after delivery: a review. Int J Bipolar Disord. 2018 Dec 2;6(1):26.
   PubMedGoogle Scholar
• Viguera AC, Whitfield T, Baldessarini RJ, et al. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. quiz 1923. Am J Psychiatry. 2007 Dec;164(12):1817–1824.
   PubMed Web of Science ®Google Scholar
• Wesseloo R, Kamperman AM, Munk-Olsen T, et al. Risk of postpartum relapse in bipolar disorder and postpartum psychosis: a systematic review and meta-analysis. Am J Psychiatry. 2016 Feb 1;173(2):117–127.
   PubMed Web of Science ®Google Scholar
• Patorno E, Huybrechts KF, Hernandez-Diaz S. Lithium use in pregnancy and the risk of cardiac malformations. N Engl J Med. 2017 Aug 31;377(9):893–894. PMID: 28854098.
   PubMedGoogle Scholar
• Severus E, Bauer M, Geddes J. Efficacy and effectiveness of lithium in the long-term treatment of bipolar disorders: an update 2018. Pharmacopsychiatry. 2018;51(5):173–176.
   PubMed Web of Science ®Google Scholar
• Hirschowitz J, Kolevzon A, Garakani A. The pharmacological treatment of bipolar disorder: the question of modern advances. Harv Rev Psychiatry. 2010;18(5):266–278.
   PubMed Web of Science ®Google Scholar
• Gershon S, Chengappa KN, Malhi GS. Lithium specificity in bipolar illness: a classic agent for the classic disorder. Bipolar Disord. 2009;11(2):34–44.
   PubMedGoogle Scholar
• Perlis RH, Sachs GS, Lafer B, et al. Effect of abrupt change from standard to low serum levels of lithium: a reanalysis of double-blind lithium maintenance data. Am J Psychiatry. 2002;159(7):1155–1159.
   PubMed Web of Science ®Google Scholar
• Rhee TG, Olfson M, Nierenberg AA, et al. 20-Year trends in the pharmacologic treatment of bipolar disorder by psychiatrists in outpatient care settings. Am J Psychiatry. 2020;177(8):706–715.
   PubMed Web of Science ®Google Scholar
• Nierenberg BP. Euthymia and disabling health conditions. World Psychiatry. 2020;19(1):58–59.
   PubMed Web of Science ®Google Scholar
• Linden M. Euthymic suffering and wisdom psychology. World Psychiatry. 2020;19(1):55–56.
   PubMed Web of Science ®Google Scholar
• Reynolds CF. Optimizing personalized management of depression: the importance of real-world contexts and the need for a new convergence paradigm in mental health. World Psychiatry. 2020;19(3):266–268.
   PubMed Web of Science ®Google Scholar
• Elsayed OH, Pahwa M, El-Mallakh RS. Pharmacologic treatment and management of bipolar disorder in adolescents. Expert Opin Pharmacother. 2022 May 27;23(10):1165–1179.
   PubMed Web of Science ®Google Scholar
• Frajo-Apor B, Kemmler G, Pardeller S, et al. Emotional intelligence in bipolar-I-disorder: a comparison between patients, unaffected siblings, and control subjects. Eur Psychiatry. 2020;63(1):e69.
   PubMed Web of Science ®Google Scholar
• Bocchetta A, Ardau R, Fanni T, et al. Renal function during long-term lithium treatment: a cross-sectional and longitudinal study. BMC Med. 2015 Jan 21;13(1):12. PMID: 25604586; PMCID: PMC4300557.
   PubMedGoogle Scholar
• Schoot TS, Molmans THJ, Grootens KP, et al. Systematic review and practical guideline for the prevention and management of the renal side effects of lithium therapy. Eur Neuropsychopharmacol. 2020Feb; 31: 16–32.10.1016/j.euroneuro.2019.11.006 Epub 2019 Dec 11. PMID: 31837914
   PubMed Web of Science ®Google Scholar
• Ljubic N, Ueberberg B, Grunze H, et al. Treatment of bipolar disorders in older adults: a review. Ann Gen Psychiatry. 2021;20(1):45.
   PubMed Web of Science ®Google Scholar
• Nolen WA, Licht RW, Young AH, et al., ISBD IGSLI Task Force Treatment. What is the optimal serum level for lithium in the maintenance treatment of bipolar disorder? A systematic review and recommendations from the ISBD/IGSLI task force on treatment with lithium. Bipolar Disord. 2019;21(5):394–409.
   PubMed Web of Science ®Google Scholar
• McKnight RF, Adida M, Budge K, et al. Lithium toxicity profile: a systematic review and meta-analysis. Lancet. 2012 Feb 25;379(9817):721–728. Epub 2012 Jan 20. PMID: 22265699.
   PubMed Web of Science ®Google Scholar
• Hayes JF, Osborn DPJ, Francis E, et al. Prediction of individuals at high risk of chronic kidney disease during treatment with lithium for bipolar disorder. BMC Med. 2021 Apr 28;19(1):99. PMID: 33906644; PMCID: PMC8080385.
   PubMed Web of Science ®Google Scholar
• Aiff H, Attman PO, Aurell M, et al. Effects of 10 to 30 years of lithium treatment on kidney function. J Psychopharmacol. 2015 May;29(5):608–614. Epub 2015 Mar 3. PMID: 25735990.
   PubMed Web of Science ®Google Scholar
• Klonsky ED , Dixon-Luinenburg , T, May , AM, et al. The critical distinction between suicidal ideation and suicide attempts. World Psychiatry. 2015 ;20(3):439–441. Epub 2015.
   Google Scholar
• Arango C, Dragioti E, Solmi M, et al. Risk and protective factors for mental disorders beyond genetics: an evidence-based atlas. World Psychiatry. 2021;20(3):417–436. DOI:10.1002/wps.20894
   PubMed Web of Science ®Google Scholar
• McDonald K, Smith T, Broadbent M, et al. Prevalence and incidence of clinical outcomes in patients presenting to secondary mental health care with mood instability and sleep disturbance. Eur Psychiatry. 2020;63(1):e59.
   PubMed Web of Science ®Google Scholar
• Pantazatos SP, Yttredahl A, Rubin-Falcone H, et al. Depression-related anterior cingulate prefrontal resting state connectivity normalizes following cognitive behavioral therapy. Eur Psychiatry. 2020;63(1):e66.
   PubMed Web of Science ®Google Scholar
• Volkmann C, Bschor T, Köhler S. Lithium treatment over the lifespan in bipolar disorders. Front Psychiatry. 2020;11:377.
   PubMed Web of Science ®Google Scholar
• Salarda EM, Zhao NO, Cnnc L, et al. Mini-review: the anti-aging effects of lithium in bipolar disorder. Neurosci Lett. 2021;759:136051.
   PubMed Web of Science ®Google Scholar
• Tampi RR, Joshi P, Bhattacharya G, et al. Evaluation and treatment of older-age bipolar disorder: a narrative review. Drugs Context. 2021;10:2021-1–8.
   Google Scholar
• Jarrett RB Can we help more?. World Psychiatry. 2020;19(2):246–247. DOI:10.1002/wps.20749
   PubMed Web of Science ®Google Scholar
• Furukawa TA, Shinohara K, Sahker E, et al. Initial treatment choices to achieve sustained response in major depression: a systematic review and network meta-analysis. World Psychiatry. 2021;20(3):387–396. DOI:10.1002/wps.20906
   PubMed Web of Science ®Google Scholar
• Mandal S, Mamidipalli SS, Mukherjee B, et al. Perspectives, attitude, and practice of lithium prescription among psychiatrists in India. Indian J Psychiatry. 2019 Sep-Oct;61(5):451–456. PMID: 31579157; PMCID: PMC6767820.
   PubMed Web of Science ®Google Scholar